Kwality Pharmaceuticals Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹375.05
- Today's High:
- ₹397.75
- Open Price:
- ₹390.05
- 52W Low:
- ₹248
- 52W High:
- ₹508.8
- Prev. Close:
- ₹387.5
- Volume:
- 20613
Company Statistics
- Market Cap.:
- ₹3.41 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹558.80 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 202.44%
Company Profile
Kwality Pharmaceuticals Ltd had its IPO on under the ticker symbol KPL.
The company operates in the sector and industry. Kwality Pharmaceuticals Ltd has a staff strength of 0 employees.
Stock update
Shares of Kwality Pharmaceuticals Ltd opened at ₹390.05 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹375.05 - ₹397.75, and closed at ₹378.
This is a -2.45% slip from the previous day's closing price.
A total volume of 20,613 shares were traded at the close of the day’s session.
In the last one week, shares of Kwality Pharmaceuticals Ltd have slipped by -2.05%.
Kwality Pharmaceuticals Ltd's Key Ratios
Kwality Pharmaceuticals Ltd has a market cap of ₹3.41 billion, indicating a price to book ratio of 1.8192 and a price to sales ratio of 1.3207.
In the last 12-months Kwality Pharmaceuticals Ltd’s revenue was ₹0 with a gross profit of ₹558.80 million and an EBITDA of ₹0. The EBITDA ratio measures Kwality Pharmaceuticals Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Kwality Pharmaceuticals Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 202.44%.
In Q1, Kwality Pharmaceuticals Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Kwality Pharmaceuticals Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 41.0224
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Kwality Pharmaceuticals Ltd’s profitability.
Kwality Pharmaceuticals Ltd stock is trading at a EV to sales ratio of 1.6309 and a EV to EBITDA ratio of 5.8179. Its price to sales ratio in the trailing 12-months stood at 1.3207.
Kwality Pharmaceuticals Ltd stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹4.07 billion
- Total Liabilities
- ₹1.23 billion
- Operating Cash Flow
- ₹-409545000.00
- Capital Expenditure
- ₹424.39 million
- Dividend Payout Ratio
- 0%
Kwality Pharmaceuticals Ltd ended 2024 with ₹4.07 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹4.07 billion while shareholder equity stood at ₹1.80 billion.
Kwality Pharmaceuticals Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹1.23 billion in other current liabilities, 214738000.00 in common stock, ₹1.59 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹21.98 million and cash and short-term investments were ₹40.67 million. The company’s total short-term debt was ₹926,766,000 while long-term debt stood at ₹729.57 million.
Kwality Pharmaceuticals Ltd’s total current assets stands at ₹1.50 billion while long-term investments were ₹0 and short-term investments were ₹3.95 million. Its net receivables were ₹488.54 million compared to accounts payable of ₹351.92 million and inventory worth ₹832.48 million.
In 2024, Kwality Pharmaceuticals Ltd's operating cash flow was ₹-409545000.00 while its capital expenditure stood at ₹424.39 million.
Comparatively, Kwality Pharmaceuticals Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹378
- 52-Week High
- ₹508.8
- 52-Week Low
- ₹248
- Analyst Target Price
- ₹
Kwality Pharmaceuticals Ltd stock is currently trading at ₹378 per share. It touched a 52-week high of ₹508.8 and a 52-week low of ₹508.8. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹362.25 and 200-day moving average was ₹338.39 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.